Herbalife posts strong Q1 2026 results
May 10, 2026 at 21:06 UTC
Key Points
- Herbalife Q1 2026 net sales rose 7.8% to $1.3 billion
- Adjusted EBITDA of $176 million exceeded company guidance
- India delivered record $275 million in net sales, up 32%
- Company targets further deleveraging and guides Q2 growth
Solid Q1 2026 performance
Herbalife reported strong financial results for the first quarter of 2026, highlighted by net sales of $1.3 billion, a 7.8% increase year over year. Management said the period marked the third consecutive quarter of year-over-year sales growth, reflecting continued momentum across the business.
Adjusted EBITDA for the quarter came in at $176 million, surpassing prior guidance. The company also reported net income attributable to Herbalife of $62 million, adjusted net income of $69 million and adjusted diluted earnings per share of $0.64.
Growth drivers and strategic focus
Herbalife attributed the quarter’s performance to momentum in international markets and progress in its personalized nutrition strategy. The company said recent acquisitions have supported these efforts, helping to advance its offerings in targeted nutrition solutions.
Chief Executive Officer Stephan Gratziani highlighted that the combination of geographic expansion and personalized nutrition initiatives has underpinned the return to sustained sales growth. These factors were cited as key contributors to both top-line gains and margin performance in Q1 2026.
India’s record contribution
India emerged as a notable growth engine for Herbalife in the first quarter. Net sales in the country reached a record $275 million, up approximately 32% year over year on a reported basis and 39% in local currency.
The strong performance in India was identified as a significant driver of the company’s overall sales increase. Herbalife grouped India within its broader international momentum, underscoring the market’s growing role in its global portfolio.
Balance sheet and leverage reduction
Herbalife reported continued improvement in its leverage metrics. The company’s total leverage ratio stood at 2.7x as of March 31, 2026, compared with 3.9x at the end of 2023, reflecting progress in reducing debt relative to earnings.
Management reaffirmed a focus on further deleveraging, stating a goal to reduce net leverage to below 2x by the end of 2026. The company framed this objective as a key financial priority alongside its growth strategy.
Outlook and Q2 2026 guidance
Looking ahead, Herbalife expects continued growth in the near term. For the second quarter of 2026, the company forecasts reported net sales to increase between 1.5% and 5.5% year over year.
Herbalife projects Q2 adjusted EBITDA in the range of $150 million to $170 million. This guidance reflects the company’s expectation of sustained demand while it continues to invest in personalized nutrition and international expansion, supported by a strengthening balance sheet.
Key Takeaways
- Herbalife combined revenue growth with margin outperformance in Q1 2026, with adjusted EBITDA above its own guidance range.
- India’s record sales and strong local-currency growth underscore the importance of high-growth international markets in Herbalife’s results.
- The company is coupling operational expansion with a clear deleveraging plan, targeting net leverage below 2x by year-end 2026.
- Q2 guidance for both sales and adjusted EBITDA points to expectations of ongoing, though more moderate, growth following a strong first quarter.
Get premium market insights delivered directly to your inbox.